Company Profile
Helius Medical Technologies Stock Price, News & Catalysts
- Ticker:
- HSDT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.10 USD (+12.90%)
Close
Last updated: August 21, 2026
93.4M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, HSDT closed up 12.9% at $2.10. No new same-company headline was identified in the current news window.
Company overview
Business overview
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms. Its business is rooted in device-based neuroscience rather than pharmaceuticals.
Geographic Base and Sector Classification
Helius is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
Business Model Characteristics
The company depends on product adoption, clinical acceptance, and the ability to expand use of its neuromodulation platform. Investors usually watch commercialization progress and regulatory or reimbursement developments.
Position Within the Biotechnology Landscape
Helius occupies a neuromodulation niche within healthcare technology. It is not biotech, but it sits close to the neuroscience device layer.
Future catalysts
- Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
Recent news
- 01
- 02
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Helius Medical Technologies (HSDT)?
Helius Medical Technologies (HSDT) most recently closed at 2.10 USD, a +12.90% move versus the previous session.
What is the market cap of Helius Medical Technologies (HSDT)?
Helius Medical Technologies currently has a market capitalization of 93.4M USD on BioPharmSignal.
What does Helius Medical Technologies do?
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms. Its business is rooted in device-based neuroscience rather than pharmaceuticals.
On which exchange is HSDT stock listed?
Helius Medical Technologies (HSDT) is associated with NASDAQ, United States, Biopharma.
What is Helius?
Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update.
Which conditions is Helius Medical Technologies targeting with Helius?
Helius Medical Technologies is associated with neuroscience based on its company overview and current catalyst commentary.
How does Helius Medical Technologies describe recent progress with Helius?
Helius is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update.
What is Medical?
Helius Medical Technologies is a medical technology company focused on neuromodulation and non-invasive approaches to neurological symptoms.